Health Care & Pharmaceuticals
American drug prices have only soared higher, even as innovation in the pharmaceutical industry continues to slacken. The effects of consolidation wreak havoc on the American healthcare system and on Americans’ well-being.
Why Universal Health Care Needs Antitrust
January 10, 2018 | by Phil Longman
The Corner: CVS/Aetna Deal, Republican Tax Bill’s Concentration Problem, Monopoly & Regional Inequality
December 7, 2017 | by Open Markets
How Big Medicine Can Ruin Medicare for All
November 15, 2017 | by Phil Longman
Date Published: June 1, 2017Americans must pay the highest drug prices in the world because of the high cost of innovation, or so say lobbyists for big pharmaceutical companies. If the United States adopted policies to bring its drug prices in line with those in other advanced nations, they warn, drug companies would be forced to cut their spending […] Continue Reading
Date Published: June 1, 2017Rising health care costs continue to erode the American standard of living. For a typical American of family of four the annual cost of health care now surpasses $25,000, or roughly the equivalent to a payroll tax of 28 percent. Such families pay more than $11,000 of this cost directly out their own pockets. The rest […] Continue Reading
Date Published: June 1, 2017When Americans buy health insurance they typically find they have fewer and fewer choices. In some states, such as Alabama, a single insurance company has a near total monopoly. In half of all metro areas, just two health insurers divide two-thirds of the market. This high degree of concentration has been building for years. A […] Continue Reading
Date Published: June 1, 2017The American consumer enjoys more choices than ever before, or so it seems. A trip to the grocery store reveals aisle after aisle of varied products marketed under countless brand names to countless specifications. Big e-commerce sites like Amazon feature a still greater plethora of choices. Yet all is not what appears to be. Take […] Continue Reading
Date Published: October 2, 2016Compared to the discourse in the other party’s nomination process, the debate between Hillary Clinton and Bernie Sanders over health-care reform may have seemed thoughtful and on point. Clinton argued that Sanders’s “Medicare for all” plan was too expensive to ever become law and was also a threat to the progress achieved by the Affordable […] Continue Reading
Join the Movement
In America today, wealth and political power are more concentrated than at any point in our country’s history.
The Open Markets Institute, formerly the Open Markets program at New America, was founded to protect liberty and democracy from these extreme -- and growing -- concentrations of private power.
Sign up to stay informed.